Skip to main content

Stroke, Acute clinical trials at UCSF
1 in progress, 1 open to new patients

  • Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3

    open to eligible people ages 18–90

    This is a study to evaluate the hypothesis that FDA cleared thrombectomy devices plus medical management leads to superior clinical outcomes in acute ischemic stroke patients at 90 days when compared to medical management alone in appropriately selected subjects with the Target mismatch profile and an MCA (M1 segment) or ICA occlusion who can be randomized and have endovascular treatment initiated between 6-16 hours after last seen well.

    Fresno, California and other locations